LENZ Therapeutics, Inc. (LENZ)
NASDAQ·Healthcare·Biotechnology
$5.57
-5.27%
Mkt Cap $171.82M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (6 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+115.4%
Consensus $12.00 vs current $5.57
NASDAQ·Healthcare·Biotechnology
$5.57
-5.27%
Mkt Cap $171.82M
Buy
6
Hold
1
Sell
0
Price Target (6 analysts)
$12.00
Range $12.00 – $12.00
+115.4%
Consensus $12.00 vs current $5.57